Ocular Genetic Diagnostic Global Market Report 2025

Description

Ocular genetic diagnostics refers to the specialized field focused on detecting and analyzing inherited genetic variations linked to eye health and vision. It involves the systematic examination of genetic factors that contribute to ocular conditions, with the goal of identifying the hereditary basis of these disorders.

The primary test types in ocular genetic diagnostics include single gene testing, panel testing, whole exome sequencing, and whole genome sequencing. Single gene testing, also called singleton testing, evaluates one specific gene at a time, typically when a mutation is strongly suspected based on clinical features or family history. Technology types include sequencing technology, polymerase chain reaction (PCR), microarray technology, and next-generation sequencing (NGS). Applications include retinal disorders, cataract diagnosis, inherited ocular diseases, and age-related macular degeneration, with end users such as hospitals, diagnostic laboratories, academic institutions, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The ocular genetic diagnostic market research report is one of a series of new reports from The Business Research Company that provides ocular genetic diagnostic market statistics, including ocular genetic diagnostic industry global market size, regional shares, competitors with a ocular genetic diagnostic market share, detailed ocular genetic diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the ocular genetic diagnostic industry. The ocular genetic diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ocular genetic diagnostics market size has grown strongly in recent years. It will grow from $0.98 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period is attributed to the early adoption of molecular diagnostic techniques, rising awareness of inherited eye disorders, expansion of academic and clinical research, increasing incidence of retinal dystrophies, and growing demand for pediatric genetic testing.

The ocular genetic diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period is driven by rising demand for personalized ophthalmic care, expansion of direct-to-consumer genetic testing, increasing investments in gene therapy trials, growth of precision medicine initiatives, and the integration of artificial intelligence in genetic data interpretation. Key trends in the forecast period include greater use of artificial intelligence-powered genetic analysis, expansion of at-home genetic testing kits, rising demand for prenatal ocular genetic screening, development of gene-specific diagnostic platforms, and advancements in cloud-based genetic data storage.

The growing prevalence of eye diseases is contributing to the expansion of the ocular genetic diagnostic market. Eye diseases include a range of medical conditions that affect the eye's structure or function and can lead to vision loss or blindness if not properly treated. This increase in eye-related conditions is primarily driven by extended use of digital screens and electronic devices, which results in eye strain, dry eye, and other visual impairments. Ocular genetic diagnostics support the management of these conditions by identifying inherited genetic components early, providing a better understanding of disease origins, and improving diagnostic accuracy and patient care strategies. For example, in February 2025, a survey conducted by the American Foundation for the Blind, a United States-based organization supporting individuals with vision impairment, found that 51.9 million American adults aged 18 and older reported some degree of vision difficulty. Among them, 3.7 million have significant trouble seeing even while wearing glasses, and 307,000 are completely blind. The remaining 47.9 million experience mild visual difficulties despite using corrective lenses. This rise in vision problems is contributing to the growing demand for genetic diagnostics in ocular healthcare.

Companies involved in this market are prioritizing the development of specialized clinical services to improve early detection, diagnosis, and personalized treatment of hereditary eye conditions. Clinical services involve the professional evaluation, diagnosis, and management of patient health concerns. For instance, in October 2024, the Singapore National Eye Centre, a public-sector specialty eye hospital in Singapore, introduced the Ocular Genetics Service. This dedicated clinical program provides focused care for patients with inherited eye conditions, integrating genetic testing, counseling, and individualized treatment planning in one setting. The initiative allows for more timely and accurate identification of genetic eye disorders while offering care that aligns with the patient's unique genetic profile. This type of clinical service reflects a broader movement toward precision medicine and integrated, patient-centered care in the ocular genetics field.

In October 2024, Ocuphire Pharma Inc., a biopharmaceutical company based in the United States that specializes in ophthalmic treatments, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition enables Ocuphire to broaden its research and development pipeline by incorporating gene therapy programs designed for rare genetic eye conditions. By combining its existing advanced-stage drug portfolio with early-stage genetic therapies, the company aims to address unmet needs in retinal degenerative diseases. Opus Genetics Inc., also based in the United States, focuses on the development of therapies for inherited retinal diseases associated with genes that cause progressive vision loss.

Major players in the ocular genetic diagnostic market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Illumina Inc., The Children's Hospital of Philadelphia, University of Iowa Hospitals and Clinics, PerkinElmer Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., ARUP Laboratories Inc., Invitae Corporation, Spark Therapeutics Inc., GeneDx LLC, Blueprint Genetics Oy, Medgenome Labs Inc., Centogene NV, PreventionGenetics LLC, Molecular Vision Laboratory LLC, Casey Eye Institute, and Moorfields Eye Hospital & UCL Institute of Ophthalmology.

North America was the largest region in the ocular genetic diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ocular genetic diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ocular genetic diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular genetic diagnostic market consists of revenues earned by entities by providing services such as molecular diagnostic services, genetic counseling services, risk assessment services, and customized genetic report services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ocular genetic diagnostic market also includes sales of genetic testing kits, laboratory reagents, and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Genetic Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular genetic diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular genetic diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ocular genetic diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test Type: Single Gene Testing; Panel Testing; Whole Exome Sequencing; Whole Genome Sequencing
2) By Technology Type: Sequencing Technology; Polymerase Chain Reaction (PCR); Microarray Technology; Next-Generation Sequencing (NGS)
3) By Application: Retinal Disorders; Cataract Diagnosis; Inherited Ocular Disorders; Age-Related Macular Degeneration
4) By End User: Hospitals; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
Subsegments:
1) By Single Gene Testing: Retinoblastoma Gene Testing (RB1); RPE65 Gene Mutation Testing; MYOC Gene Testing (Glaucoma); OPA1 Gene Testing (Optic Atrophy); BEST1 Gene Testing (Best Disease)
2) By Panel Testing: Inherited Retinal Disease (IRD) Panels; Glaucoma Genetic Panels; Macular Dystrophy Panels; Optic Neuropathy Panels; Syndromic Ocular Disorder Panels
3) By Whole Exome Sequencing (WES): Trio Exome Sequencing; Diagnostic Exome Sequencing; Exome Reanalysis Services; Rapid Exome Testing; Prenatal Exome Sequencing
4) By Whole Genome Sequencing (WGS): Clinical Whole Genome Sequencing; Rapid Whole Genome Sequencing; Pediatric Genome Sequencing; Prenatal Whole Genome Sequencing; Ultra-Rare Eye Disease Genome Sequencing
Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Illumina Inc.; The Children's Hospital of Philadelphia; University of Iowa Hospitals and Clinics; PerkinElmer Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; ARUP Laboratories Inc.; Invitae Corporation; Spark Therapeutics Inc.; GeneDx LLC; Blueprint Genetics Oy; Medgenome Labs Inc.; Centogene NV; PreventionGenetics LLC; Molecular Vision Laboratory LLC; Casey Eye Institute; Moorfields Eye Hospital & UCL Institute of Ophthalmology.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38589

1. Executive Summary

2. Ocular Genetic Diagnostic Market Characteristics

3. Ocular Genetic Diagnostic Market Trends And Strategies

4. Ocular Genetic Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ocular Genetic Diagnostic Growth Analysis And Strategic Analysis Framework

5.1. Global Ocular Genetic Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ocular Genetic Diagnostic Market Growth Rate Analysis
5.4. Global Ocular Genetic Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ocular Genetic Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ocular Genetic Diagnostic Total Addressable Market (TAM)

6. Ocular Genetic Diagnostic Market Segmentation

6.1. Global Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Gene Testing
Panel Testing
Whole Exome Sequencing
Whole Genome Sequencing
6.2. Global Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Technology
Polymerase Chain Reaction (PCR)
Microarray Technology
Next-Generation Sequencing (NGS)
6.3. Global Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinal Disorders
Cataract Diagnosis
Inherited Ocular Disorders
Age-Related Macular Degeneration
6.4. Global Ocular Genetic Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Academic And Research Institutes
Other End Users
6.5. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Single Gene Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinoblastoma Gene Testing (RB1)
RPE65 Gene Mutation Testing
MYOC Gene Testing (Glaucoma)
OPA1 Gene Testing (Optic Atrophy)
BEST1 Gene Testing (Best Disease)
6.6. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Panel Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inherited Retinal Disease (IRD) Panels
Glaucoma Genetic Panels
Macular Dystrophy Panels
Optic Neuropathy Panels
Syndromic Ocular Disorder Panels
6.7. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Exome Sequencing (WES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trio Exome Sequencing
Diagnostic Exome Sequencing
Exome Reanalysis Services
Rapid Exome Testing
Prenatal Exome Sequencing
6.8. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Genome Sequencing (WGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Whole Genome Sequencing
Rapid Whole Genome Sequencing
Pediatric Genome Sequencing
Prenatal Whole Genome Sequencing
Ultra-Rare Eye Disease Genome Sequencing

7. Ocular Genetic Diagnostic Market Regional And Country Analysis

7.1. Global Ocular Genetic Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ocular Genetic Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ocular Genetic Diagnostic Market

8.1. Asia-Pacific Ocular Genetic Diagnostic Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ocular Genetic Diagnostic Market

9.1. China Ocular Genetic Diagnostic Market Overview
9.2. China Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ocular Genetic Diagnostic Market

10.1. India Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ocular Genetic Diagnostic Market

11.1. Japan Ocular Genetic Diagnostic Market Overview
11.2. Japan Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ocular Genetic Diagnostic Market

12.1. Australia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ocular Genetic Diagnostic Market

13.1. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ocular Genetic Diagnostic Market

14.1. South Korea Ocular Genetic Diagnostic Market Overview
14.2. South Korea Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ocular Genetic Diagnostic Market

15.1. Western Europe Ocular Genetic Diagnostic Market Overview
15.2. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ocular Genetic Diagnostic Market

16.1. UK Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ocular Genetic Diagnostic Market

17.1. Germany Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ocular Genetic Diagnostic Market

18.1. France Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ocular Genetic Diagnostic Market

19.1. Italy Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ocular Genetic Diagnostic Market

20.1. Spain Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ocular Genetic Diagnostic Market

21.1. Eastern Europe Ocular Genetic Diagnostic Market Overview
21.2. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ocular Genetic Diagnostic Market

22.1. Russia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ocular Genetic Diagnostic Market

23.1. North America Ocular Genetic Diagnostic Market Overview
23.2. North America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ocular Genetic Diagnostic Market

24.1. USA Ocular Genetic Diagnostic Market Overview
24.2. USA Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ocular Genetic Diagnostic Market

25.1. Canada Ocular Genetic Diagnostic Market Overview
25.2. Canada Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ocular Genetic Diagnostic Market

26.1. South America Ocular Genetic Diagnostic Market Overview
26.2. South America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ocular Genetic Diagnostic Market

27.1. Brazil Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ocular Genetic Diagnostic Market

28.1. Middle East Ocular Genetic Diagnostic Market Overview
28.2. Middle East Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ocular Genetic Diagnostic Market

29.1. Africa Ocular Genetic Diagnostic Market Overview
29.2. Africa Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ocular Genetic Diagnostic Market Competitive Landscape And Company Profiles

30.1. Ocular Genetic Diagnostic Market Competitive Landscape
30.2. Ocular Genetic Diagnostic Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. The Children's Hospital of Philadelphia Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. University of Iowa Hospitals and Clinics Overview, Products and Services, Strategy and Financial Analysis

31. Ocular Genetic Diagnostic Market Other Major And Innovative Companies

31.1. PerkinElmer Inc.
31.2. Natera Inc.
31.3. Myriad Genetics Inc.
31.4. Fulgent Genetics Inc.
31.5. ARUP Laboratories Inc.
31.6. Invitae Corporation
31.7. Spark Therapeutics Inc.
31.8. GeneDx LLC
31.9. Blueprint Genetics Oy
31.10. Medgenome Labs Inc.
31.11. Centogene NV
31.12. PreventionGenetics LLC
31.13. Molecular Vision Laboratory LLC
31.14. Casey Eye Institute
31.15. Moorfields Eye Hospital & UCL Institute of Ophthalmology

32. Global Ocular Genetic Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ocular Genetic Diagnostic Market

34. Recent Developments In The Ocular Genetic Diagnostic Market

35. Ocular Genetic Diagnostic Market High Potential Countries, Segments and Strategies

35.1 Ocular Genetic Diagnostic Market In 2029 - Countries Offering Most New Opportunities
35.2 Ocular Genetic Diagnostic Market In 2029 - Segments Offering Most New Opportunities
35.3 Ocular Genetic Diagnostic Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer